【レポートの概要（一部）】
01. Executive Summary
02.List of Abbreviations
03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04.Product Profiles
04.1.1 Aranesp
04.1.2 Epogen/Procrit
04.1.3 Mircera
04.1.4 Renvela
04.1.5 Avapro
04.1.6 Bystolic
05.Market Research Methodology
05.1 Market Research Process
05.2 Research Methodology
06.Introduction
07.Disease Overview
07.1 Etiology
07.2 Epidemiology
07.2.1 Mortality
07.2.2 Prevalence of CKD
08.Pipeline Analysis
08.1 Emerging Treatment Options
09.Market Landscape
09.1 Market Overview
09.2 Market Size and Forecast
09.3 Five Forces Analysis
10.Segmentation of Global CKD Market by Route of Administration
10.1 Oral
10.2 SC
10.3 IV
11.Segmentation of Global CKD Market by Mechanism of Action
11.1 ARBs
11.2 ACEIs
11.3 ESAs
11.4 PH Binders
11.5 Vasodilators
12.Geographical Segmentation
12.1 CKD Drugs Market in Americas
12.1.1 Market Size and Forecast
12.2 CKD Drugs Market in EMEA Region
12.2.1 Market Size and Forecast
12.3 CKD Drugs Market in APAC Region
12.3.1 Market Size and Forecast
13.Buying Criteria
14.Market Growth Drivers
15.Drivers and their Impact
16.Market Challenges
17.Impact of Drivers and Challenges
18.Market Trends
19.Trends and their Impact
20.Vendor Landscape
20.1 Competitive Scenario
20.1.1 Key News
20.1.2 Mergers and Acquisitions
20.2 Market Share Analysis 2014
20.2.1 Competitive Assessment of Top Drugs Used for CKD Treatment
20.2.2 Amgen
20.2.3 Actavis
20.2.4 Johnson & Johnson
20.2.5 F. Hoffmann-La Roche
20.2.6 Sanofi
20.3 Other Prominent Vendors
21.Key Vendor Analysis
21.1 Amgen
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Business Segmentation by Revenue 2013
21.1.4 Product Portfolio by Revenue 2013
21.1.5 Business Segmentation by Revenue 2012 and 2013
21.1.6 Geographical Segmentation by Revenue 2013
21.1.7 Business Strategy
21.1.8 Recent Developments
21.1.9 SWOT Analysis
21.2 Actavis
21.2.1 Key Facts
21.2.2 Business Description
21.2.3 Business Segmentation
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Sales by Geography
21.2.6 Business Strategy
21.2.7 Key Information
21.2.8 SWOT Analysis
21.3 Johnson & Johnson
21.3.1 Key Facts
21.3.2 Business Overview
21.3.3 Business Segmentation by Revenue 2013
21.3.4 Business Segmentation by Revenue 2012 and 2013
21.3.5 Geographical Segmentation by Revenue 2013
21.3.6 Business Strategy
21.3.7 Recent Developments
21.3.8 SWOT Analysis
21.4 F. Hoffmann-La Roche Ltd.
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation
21.4.4 Business Segmentation by Revenue 2012 and 2013
21.4.5 Sales by Geography
21.4.6 Business Strategy
21.4.7 Key Information
21.4.8 SWOT Analysis
21.5 Sanofi SA
21.5.1 Key Facts
21.5.2 Business Description
21.5.3 Business Segmentation
21.5.4 Revenue by Business Segmentation
21.5.5 Revenue Comparison 2012 and 2013
21.5.6 Sales by Geography
21.5.7 Business Strategy
21.5.8 Key Developments
21.5.9. SWOT Analysis
22.Other Reports in this Series
[List of Exhibits]
Exhibit 1: Segmentation of Global CKD Drugs Market
Exhibit 2: Market Research Methodology
Exhibit 3: Stages of CKD
Exhibit 4: Causes of CKD
Exhibit 5: Prevalence of CKD among NHANES (US) Participants by CKD Stage 1988-2012
Exhibit 6: Global CKD Drugs Market 2014-2019 (US$ billion)
Exhibit 7: Drivers and Challenges in Global CKD Drugs Market
Exhibit 8: Segmentation of Global CKD Drugs Market by Route of Administration
Exhibit 9: Segmentation of Global CKD Drugs Market by Mechanism of Action
Exhibit 10: Segmentation of Global CKD Drugs Market by Geography 2014
Exhibit 11: Segmentation of Global CKD Drugs Market by Geography 2019
Exhibit 12: Segmentation of Global CKD Drugs Market by Geography 2014-2019
Exhibit 13: CKD Drugs Market in Americas 2014-2019 (US$ billion)
Exhibit 14: CKD Drugs Market in EMEA Region 2014-2019 (US$ billion)
Exhibit 15: CKD Drugs Market in APAC Region 2014-2019 (US$ billion)
Exhibit 16: Comparison of Percentage of Population Age 65 and Older 2012 and 2050
Exhibit 17: Revenue Comparison of Top Drugs Used for Treatment of CKD 2013 (US$ million)
Exhibit 18: Epogen: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 19: Aranesp: Revenue Comparison and YoY Growth 2011-2013 (US$ million)
Exhibit 20: Bystolic: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 21: Procrit: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 22: Mircera: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 23: Renvela: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 24: Avapro: Revenue Comparison and YoY Growth Rate 2011-2013 (US$ million)
Exhibit 25: Amgen: Business Segmentation by Revenue 2013
Exhibit 26: Amgen: Product Portfolio by Revenue 2013
Exhibit 27: Amgen: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 28: Amgen: Geographical Segmentation by Revenue 2013
Exhibit 29: Global CKD Drugs Market Market Business Segmentation 2013
Exhibit 30: Global CKD Drugs Market Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 31: Actavis : Sales by Geography (in US$ million)
Exhibit 32: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 33: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 34: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Exhibit 35: Business Segmentation of F. Hoffmann-La Roche Ltd. 2013
Exhibit 36: F. Hoffmann-La Roche Ltd.: Business Segmentation by Revenue 2012 and 2013
Exhibit 37: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Pharmaceuticals Division)
Exhibit 38: F. Hoffmann-La Roche Ltd.: Sales by Geography 2013 (Diagnostics Division)
Exhibit 39: Sanofi SA: Business Segmentation
Exhibit 40: Sanofi SA: Revenue by Business Segmentation 2013
Exhibit 41: Sanofi SA: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 42: Sanofi SA: Sales Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル：慢性腎臓病（CKD）治療薬の世界市場2015-2019■ 英文：Global Chronic Kidney Disease (CKD) Drugs Market 2015-2019
■ 発行日：2015年3月11日
■ 調査会社：Technavio
■ 商品コード：IRTNTR5417
■ 調査対象地域：グローバル
- 医療用メンブレンの世界市場予測（～2022年）“The medical membranes market is projected to grow at CAGR of 9.2% from 2017 to 2022.”The medical membranes market is projected to grow from USD 2.13 billion in 2017 to USD 3.31 billion by 2022, at a CAGR of 9.2% during the forecast period. The demand for medical membranes is expected to increase in the near future, owing to the rising prevalence of ESRD, globally. Membranes are required for filtr …
- 世界の整形外科検査（医療機器）市場2014：主要企業の戦略的分析Complete report $12,500. Individual company assessments $1,900. A strategic assessment of the competitive environment is unquestionably one of the highest priority management responsibilities, the task crucial to business survival, growth and profitability. Timely and factual competitive intelligence is vital to the success of all business functions, especially Planning, Marketing, R&D a …
- マイクロブルワリー（地ビール醸造所）用装置の世界市場2017-2021About Microbrewery EquipmentMicrobrewery equipment refers to the set of equipment used to produce craft beer. Some of the major categories of microbrewery equipment are mashing systems, cooling systems, fermentation systems, controlling systems, and cleaning systems. The average lifespan of microbrewery equipment is four years. Most of the vendors offer the equipment along with warranty and good a …
- ガイガー＝ミュラー計数管（GM管）の世界市場2017-2021About Geiger CounterGeiger counter, also known as Geiger-Müller counter, is a type of radiation detection and measurement device, which was invented by Hans Geiger and Walther Müller in 1928. It is a type of gas-filled detector that detects alpha, beta, and gamma ionizing radiations. It consists of a Geiger-Müller tube filled with inert gases such as helium, neon, or argon at low pressure, a count …
- アルミニウムダイカスト機械の世界市場：HPDC、LPDC、その他Global Aluminum Die Casting Machinery Market: About this market Technavio’s aluminum die casting machinery market analysis considers sales from HPDC, LPDC, and others. Our analysis also considers the sales of aluminum die casting machinery in APAC, Europe, MEA, North America, and South America. In 2018, the HPDC segment had a significant market share, and this trend is expected to continue over th …
- 2014年戦略提言：ヨーロッパ核酸検査市場This comprehensive five-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. The report explores business and technological trends in major European countries (France, Germany, Italy, Spain, UK); provides 5-year test volume/sales forecasts; estim …
- 医療レポート：Nonalcoholic Steatohepatitis-疫学予測（～2022）EpiCast Report: Nonalcoholic Steatohepatitis - Epidemiology Forecast to 2022 Summary Nonalcoholic steatohepatitis (NASH) is a common, often clinically silent liver disease characterized by the presence of a fatty, inflamed, and damaged liver. It resembles alcoholic liver disease, but occurs in people who drink little or no alcohol. NASH is becoming increasingly common with the alarming epidemic of …
- 自動車変速機エンジニアリングサービスアウトソーシングの世界市場：設計、試作、試験、システムエンジニアリング＆インテグレーションThe global automotive transmission engineering services outsourcing market is projected to grow at a CAGR of 5.66% during the forecast period, to reach USD 12.92 Billion by 2021, from an estimated USD 9.81 Billion in 2016. The base year for the report is 2015, and the forecast year is 2021. The increasing sales of passenger cars, stringent emission norms, and adoption of new technologies such as h …
- 世界の小型自動車用OE排気装置市場【2015年1月更新版】This latest just-auto report edition offers a global review of the OE automotive exhaust systems sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE exhaust systems market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their str …
- アンチドローンの世界市場：レーザーシステム、キネティックシステム、電子システムThe anti-drone market is expected to grow at CAGR of 23.89% between 2017 and 2022. The key drivers responsible for this are increased security breach incidences by the unidentified drones and increased terrorism and illicit activities. The military and defense segment is expected to hold the major share of market in 2016. The use of drones for border trespassing and smuggling has increased, thereb …
- 可変風量（VAV）装置の世界市場予測（～2024年）Increasing demand from commercial buildings and industrial buildings to drive the overall growth of variable air volume (VAV) systems marketThe variable air volume (VAV) systems market size is expected to grow from USD 11.8 billion in 2019 to USD 16.0 billion by 2024, at a CAGR of 6.3% during the forecast period. The variable air volume (VAV) systems market is driven by various factors, such as hi …
- エンジニアリング・プラスチックの世界市場The engineering plastic market presents huge potential for growth in the coming years. Engineering plastics market is experiencing rapid growth, which is expected to continue in the near future, mainly driven by ability of engineering plastics to replace metals in various end- user industries. They are preferred mainly due to their properties such as high dimensional stability, good strength, high …
- キトサンの世界市場2015-2019About Chitosan Chitosan is a natural polysaccharide extracted from the shells of crustaceans such as shrimps and crabs. Chitin and chitosan, the naturally abundant and renewable polymers, have excellent properties such as bio-compatibility, biodegradability, non-toxicity, and adsorption. The cost of chitosan depends on the quality of the product. Chitosan is used in a wide range of applications su …
- 世界のマイクログリッド市場予測＆分析To provide tailored, efficient, and reliable energy services to the end users, microgrid employs and integrates a wide range of distributed energy technologies such as generation, storage and advanced controls, metering and communications into a controlled system that manages energy generation, transmission, distribution, and usage on a small scale as compared to the conventional macrogrid. The re …
- サスペンション（懸架装置）の世界市場予測（～2021）The suspension system market size is projected to grow at a CAGR of 5.11% during the forecast period, to reach USD 67.22 Billion by 2021. Increasing demand for riding comfort, stability, better cornering, safety, luxury, technological advancements, along with stringent emission regulations and fuel efficiency standards enforced by the different legislative bodies across the globe are driving the s …
